A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor.

Nagy ZS, Rui H, Stepkowski SM, Karras J, Kirken RA. A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor. J Immunol. 2006 Oct 15; 177(8):5032-40.

View in: PubMed

subject areas

Apoptosis
Cell Line, Tumor
Cell Survival
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Interleukin-2
NF-kappa B
Phosphorylation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
STAT3 Transcription Factor
STAT5 Transcription Factor

authors with profiles

Robert Kirken

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support